SCHEMBL4035896

SCHEMBL4035896

Cc1nc(N2CCOCC2)[nH]c1Br

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.55
TSHR P16473 3/20 0.55
MEN1 O00255 2/20 0.55
HSD17B10 Q99714 1/20 0.55
PIM1 P11309 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.49
TP53 P04637 1/20 0.45
ALDH1A1 P00352 2/20 0.42
GAA P10253 1/20 0.39
POLB P06746 2/20 0.38
KDM4E B2RXH2 2/20 0.37
HPGD P15428 1/20 0.37
NUDT1 P36639 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12685246 0.81 PIM1 (0.57) KMT2ATSHRMEN1HSD17B10PIM1
SCHEMBL9761124 0.72 KMT2A (0.52) KMT2ATSHRMEN1HSD17B10PIM1
SCHEMBL1759383 0.70 PIM1 (1.00) PIM1TP53
SCHEMBL30783861 0.69 KMT2A (0.48) KMT2ATSHRMEN1HSD17B10PIM1
SCHEMBL1707833 0.68 ALDH1A1 (0.56) KMT2AMEN1HSD17B10SMN1; SMN2TP53
SCHEMBL11855734 0.68 GAA (0.56) KMT2ATSHRMEN1HSD17B10SMN1; SMN2
SCHEMBL21914523 0.67 PIM1 (0.49) KMT2ATSHRMEN1HSD17B10PIM1
SCHEMBL22587289 0.66 KMT2A (0.68) KMT2ATSHRMEN1HSD17B10SMN1; SMN2
SCHEMBL19145306 0.65 TP53 (0.64) KMT2AMEN1HSD17B10SMN1; SMN2TP53
SCHEMBL30766045 0.65 KMT2A (0.51) KMT2ATSHRMEN1HSD17B10PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725544-B1 3-[4-HETEROCYCLYL-1,2,3-TRIAZOL-1-YL]-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES BOEHRINGER INGELHEIM PHARMA (US) 2009-05-27 EP disclosed